Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

OBJECTIVE: Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in...

Descripció completa

Dades bibliogràfiques
Autors principals:	Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L
Format:	Journal article
Idioma:	English
Publicat:	2012

Ítems similars

ERYTHROPOIETIN - A CANDIDATE TREATMENT FOR MOOD SYMPTOMS AND COGNITIVE DYSFUNCTION IN DEPRESSION
per: Miskowiak, K, et al.
Publicat: (2011)

Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.
per: Miskowiak, K, et al.
Publicat: (2016)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
per: Miskowiak, K, et al.
Publicat: (2010)

Neural correlates of improved executive function following erythropoietin treatment in mood disorders
per: Miskowiak, K, et al.
Publicat: (2016)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
per: Paulson Olaf B, et al.
Publicat: (2010-10-01)

Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder
per: Miskowiak, K, et al.
Publicat: (2018)

Erythropoietin as candidate for supportive treatment of severe COVID-19
per: Hannelore Ehrenreich, et al.
Publicat: (2020-06-01)

Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning Approach
per: Søren F. V. Nielsen, et al.
Publicat: (2019-11-01)

Erythropoietin enhances hippocampal response during memory retrieval in humans.
per: Miskowiak, K, et al.
Publicat: (2007)

Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial
per: Jeff Zarp Petersen, et al.
Publicat: (2018-11-01)

Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.
per: Miskowiak, K, et al.
Publicat: (2008)

Is negative self-referent bias an endophenotype for depression? An fMRI study of emotional self-referent words in twins at high vs. low risk of depression
per: Miskowiak, K, et al.
Publicat: (2017)

The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.
per: Maj Vinberg, et al.
Publicat: (2015-01-01)

Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review
per: Ida Seeberg, et al.
Publicat: (2018-07-01)

Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients
per: Miskowiak, K, et al.
Publicat: (2009)

Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients
per: Miskowiak, K, et al.
Publicat: (2009)

Differences in neural and cognitive response to emotional faces in middle-aged dizygotic twins at familial risk of depression
per: Miskowiak, K, et al.
Publicat: (2017)

Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial
per: Lejla Sjanic Schmidt, et al.
Publicat: (2018-04-01)

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
per: Miskowiak, K, et al.
Publicat: (2009)

Is aberrant affective cognition an endophenotype for affective disorders? A monozygotic twin study
per: Meluken, I, et al.
Publicat: (2018)

Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.
per: Miskowiak, K, et al.
Publicat: (2007)

Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial.
per: Kirsa M Demant, et al.
Publicat: (2015-01-01)

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.
per: Miskowiak, K, et al.
Publicat: (2010)

Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives
per: Kjaerstad, H, et al.
Publicat: (2019)

Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?—A Perspective Paper
per: Lars Vedel Kessing, et al.
Publicat: (2018-10-01)

Predictors of mood and activity instability in participants with newly diagnosed bipolar disorder – Exploratory findings from a prospective cohort study
per: Anton Julius von Hofacker, et al.
Publicat: (2024-01-01)

Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.
per: Miskowiak, K, et al.
Publicat: (2008)

Executive dysfunction and autobiographical memory retrieval in recovered depressed women.
per: Haddad, A, et al.
Publicat: (2014)

Erythropoietin enhances hippocampal long-term potentiation and memory
per: El-Kordi Ahmed, et al.
Publicat: (2008-09-01)

Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)—recommendations
per: Faurholt-Jepsen, M, et al.
Publicat: (2019)

Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)—recommendations
per: Faurholt-Jepsen, M, et al.
Publicat: (2019)

Erythropoietin – a potential tool in the treatment of depressive disorders?
per: G. Simões, et al.
Publicat: (2022-06-01)

Erythropoietin improves operant conditioning and stability of cognitive performance in mice
per: Ehrenreich Hannelore, et al.
Publicat: (2009-07-01)

Lack of effect of tyrosine depletion on mood in recovered depressed women.
per: McTavish, S, et al.
Publicat: (2005)

Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues
per: Martin Begemann, et al.
Publicat: (2021-09-01)

Latent Classes of Symptoms related to Clinically Depressed Mood in Adolescents
per: Eva Henje Blom, et al.
Publicat: (2014-05-01)

Affective disorders: eliminate WArning signs and REstore functioning—AWARE—a randomised controlled multimodule intervention study, presentation of design and intervention
per: Maj Vinberg, et al.
Publicat: (2022-05-01)

Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial.
per: Adams, S, et al.
Publicat: (2013)

Bipolar mood disorder and treatment-resistant depression
per: Rybakowski Janusz K
Publicat: (2010-04-01)

Associations between the cortisol awakening response and patient-evaluated stress and mood instability in patients with bipolar disorder: an exploratory study
per: Maria Faurholt-Jepsen, et al.
Publicat: (2021-03-01)